1-2 of 2
Claudine Wack
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma

Clinical Trials & Observations
Thomas Martin, Rachid Baz, Don M. Benson, Nikoletta Lendvai, Jeffrey Wolf, Pamela Munster, Alexander M. Lesokhin, Claudine Wack, Eric Charpentier, Frank Campana, Ravi Vij
Journal: Blood
Blood (2017) 129 (25): 3294–3303.
https://doi.org/10.1182/blood-2016-09-740787
Published: 2017
Journal Articles

Preliminary Results from a Phase Ib Study of Isatuximab in Combination with Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, MD, Joseph Mikhael, MD, Saad Z Usmani, MD FACP, Noopur Raje, MD, William Bensinger, MD, Frank Campana, MD, Lei Gao, Franck Dubin, Claudine Wack, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2016) 128 (22): 2123.
https://doi.org/10.1182/blood.V128.22.2123.2123
Published: 2016